What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
Activities addition Advisory Committee agencies agents agreed amendment animals Appendix applications appropriate approval asked assessment Attachment authority Bethesda biological biotechnology cells chemical Class concerns consideration considered containment Department Describe determine developed Director discussion disease document Drug effects environment environmental evaluation exist experimental experiments facility Federal Register felt field testing genetic Gottesman group document human important indicate Institutes of Health introduced involving issues laboratory language material meeting methods microorganisms modified organism National Institutes nature NIH Guidelines notice October Office organisms patients pesticides Ph.D plant possible potential present procedures proposed Protection protocols questions recombinant DNA recombinant DNA molecules regulations regulatory release request requirements response result Rifkin risk safety Science scientific species studies submitted substances suggested techniques testing thought transfer TSCA University vector
Page 98 - ... medical treatments are available if injury occurs and, if so, what they consist of, or where further information may be obtained. 7) An explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights, and whom to contact in the event of a research-related injury to the subject.
Page 97 - A statement that the study involves research, an explanation of the purposes of the research and the expected duration of the subject's participation, a description of the procedures to be followed, and identification of any procedures which are experimental...
Page 96 - No informed consent, whether oral or written, may Include any exculpatory language through which the subject or the representative is made to waive or appear to waive any of the subject's legal rights, or releases or appears to release the investigator, the sponsor, the institution or its agents from liability for negligence.
Page 119 - Environmental Assessment": (a) Means a concise public document for which a Federal agency is responsible that serves to: (1) Briefly provide sufficient evidence and analysis for determining whether to prepare an environmental Impact statement or a finding of no significant impact.
Page 237 - Protection of Proprietary Data. In general, the Freedom of Information Act requires Federal agencies to make their records available to the public upon request. However, this requirement does not apply to, among other things, "trade secrets and commercial and financial information obtained from a person and privileged or confidential.
Page 363 - any technique that uses living organisms (or parts of organisms) to make or modify products, to improve plants or animals, or to develop microorganisms for specific uses.
Page 117 - The working group also has representatives from the US Department of Agriculture (USDA), the Food and Drug Administration (FDA), and the Environmental Protection Agency (EPA), and ad hoc consultants.
Page 394 - October 29. 1984 meeting of the Recombinant DNA Advisory Committee of the National Institutes of Health.
Page 230 - Definition of Recombinant DNA Molecules. In the context of these Guidelines, recombinant DNA molecules are defined as either: (i) Molecules which are constructed outside living cells by joining natural or synthetic DNA segments to DNA molecules that can replicate in a living cell, or (ii) DNA molecules that result from the replication of those described in (i) above.
Page 96 - Except as provided elsewhere in this policy, no investigator may involve a human being as a subject in research covered by this policy unless the investigator has obtained the legally effective informed consent of the subject or the subject's legally authorized representative.